Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Precision Biosciences Inc (Precision BioSciences) is a biotechnology company, that develops and commercializes gene therapy and cancer immunotherapy. The company intends to its ARCUS technology, a proprietary genome editing platform, which combines specificity and efficacy, on the development of food, fuel and feed-based products. Precision BioSciences ARCUS technology helps improve genes related to crop quality, yield, and performance traits and strives to advance food products. The company also applies its ARCUS technology to the development of cell-based immunotherapies to cure genetic diseases. Precision BioSciences genome editing platform is derived from a natural genome editing enzyme, homing endonuclease. The company partners with various pharmaceutical and biotech companies to develop novel therapies for the treatment of cancer. Precision BioSciences is headquartered in Durham, North Carolina, the US.
Headquarters
United States of America
Address
302 E Pettigrew St Ste A100, Durham, North Carolina, 27701-2393
Website
precisionbiosciences.com
Telephone
1 919 3145512
No of Employees
109
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
DTIL (NASD)
Revenue (2022)
$48.7M
94.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
45.1%
(2022 vs 2021)
Market Cap*
$83.7M
Net Profit Margin (2022)
XYZ
71.7%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Products | Services |
|---|---|
| ARCUS Genome Editing Platform | Site-Specific Genome Modifications |
Competitor Comparison
| Key Parameters | Precision Biosciences Inc | Beam Therapeutics Inc | Caribou Biosciences Inc | Eurofins Genomics Blue Heron LLC | GeneCopoeia Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Durham | Cambridge | Berkeley | Bothell | Rockville |
| State/Province | North Carolina | Massachusetts | California | Washington | Maryland |
| No. of Employees | 109 | 436 | 158 | - | 20 |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Michael Amoroso | Chief Executive Officer; President; Director | Executive Board | 2021 | - |
| Derek Jantz, Ph.D. | Chief Scientific Officer; Director | Executive Board | - | - |
| Juli Blanche | Chief People Officer | Senior Management | 2022 | - |
| Alan List, M.D | Chief Medical Officer | Senior Management | 2021 | - |
| Victor Bartsevich, Ph.D. | Director - Genome Editing Technology Development | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer